Stem cells in bone diseases: current clinical practice

被引:26
作者
Beyth, Shaul [1 ]
Schroeder, Josh [1 ]
Liebergall, Meir [1 ]
机构
[1] Hadassah Hebrew Univ Med Ctr, Dept Orthoped Surg, IL-91120 Jerusalem, Israel
关键词
stem cells; mesenchymal stem cells; bone; fracture non-union; osteogenesis imperfecta; infantile hypophosphatasia; MARROW STROMAL CELLS; MESENCHYMAL CELLS; IN-VITRO; THERAPY; TRANSPLANTATION; REPAIR; PROLIFERATION; CHILDREN; AGE; RESISTANT;
D O I
10.1093/bmb/ldr035
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction: Bone is an obvious candidate tissue for stem cell therapy. This review provides an update of existing stem cell-based clinical treatments for bone pathologies. Sources of data: A systematic computerized literature search was conducted. The following databases were accessed on 10 February 2011: NIH clinical trials database, PubMed, Ovid and Cochrane Reviews. Areas of agreement: Stem cell therapy offers new options for bone conditions, both acquired and inherited. Areas of controversy: There is still no agreement on the exact definition of 'mesenchymal stem cells'. Consequently, it is difficult to appreciate the effect of culture expansion and the feasibility of allogeneic transplantation. Growing points: Based on the sound foundations of pre-clinical research, stem cell-based treatments and protocols have recently emerged. Areas timely for developing research: Well-designed prospective clinical trials are needed in order to establish and develop stem cell therapy for bone diseases.
引用
收藏
页码:199 / 210
页数:12
相关论文
共 53 条
[1]
Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]
The Therapeutic Applications of Multipotential Mesenchymal/Stromal Stem Cells in Skeletal Tissue Repair [J].
Arthur, Agnieszka ;
Zannettino, Andrew ;
Gronthos, Stan .
JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 218 (02) :237-245
[3]
Augello A, 2010, EUR CELLS MATER, V20, P121
[4]
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[5]
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[6]
Bianco P, J CELL BIOCH, V112, P1713
[7]
Bianco P, 2010, HUM GENE THER, V21, P1057, DOI 10.1089/hum.2010.136
[8]
Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines [J].
Birnbaum, Tobias ;
Roider, Julia ;
Schankin, Christoph J. ;
Padovan, Claudio S. ;
Schichor, Christian ;
Goldbrunner, Roland ;
Straube, Andreas .
JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (03) :241-247
[9]
Activation and function of natural killer cell responses during viral infections [J].
Biron, CA .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :24-34
[10]
IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis [J].
Bouffi, Carine ;
Bony, Claire ;
Courties, Gabriel ;
Jorgensen, Christian ;
Noel, Daniele .
PLOS ONE, 2010, 5 (12)